Clinical Trials · NCT06856291
Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- ETH Zurich
- Enrollment
- 40
- Start date
- Mar 2025
- Locations
- 1 site, Switzerland
- Primary endpoint
- Change in body weight (%)